Pfizer Settles With Final Defendant in Mektovi Patent Lawsuit

Pfizer Inc.’s Array BioPharma Inc. settled its patent-infringement suit against Indian company Alembic Pharmaceuticals Ltd. over the skin-cancer drug Mektovi, ending a dispute that had previously included Sandoz Inc.

Alembic is blocked from making or selling the contested product except as provided for in the settlement agreement, according to the parties stipulation of dismisal, signed by Judge Gregory B. Williams on Tuesday in the US District Court for the District of Delaware. Specific terms of the settlement weren’t disclosed.

Array sued Alembic in September 2022, alleging the company infringed six patents for the drug used to treat skin ...